Price Alert

Bristol-Myers Squibb (BMY)

NYSE: BMY · Real-Time Price · USD

48.47

0.66 (1.38%)

At close: Aug 15, 2025, 3:59 PM

48.50

0.07%

After-hours: Aug 15, 2025, 07:58 PM EDT

Bristol-Myers Squibb Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021
Period Ending	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021
Revenue	12.27B	11.2B	12.34B	11.89B	12.2B	11.87B	11.48B	10.97B	11.23B	11.34B	11.41B	11.22B	11.89B	11.65B	11.98B	11.62B	11.7B	11.07B
Cost of Revenue	4.2B	3.86B	4.92B	5.28B	5.4B	5.28B	4.99B	4.75B	5.1B	4.82B	4.92B	4.77B	5.09B	4.89B	4.79B	4.86B	4.99B	4.99B
Gross Profit	8.07B	7.34B	7.42B	6.62B	6.8B	6.59B	6.49B	6.22B	6.13B	6.52B	6.49B	6.45B	6.79B	6.76B	7.19B	6.77B	6.71B	6.09B
Operating Income	4.12B	3.52B	2.53B	2.29B	2.58B	1.53B	1.95B	2.1B	1.94B	2.45B	1.71B	2.23B	2.69B	2.71B	2.23B	1.73B	1.56B	2.2B
Interest Income	139M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Pretax Income	1.77B	2.97B	175M	1.68B	1.29B	-11.52B	1.67B	2.14B	1.86B	2.77B	1.86B	2.21B	1.96B	1.69B	1.86B	2.16B	1.55B	2.53B
Net Income	1.31B	2.46B	72M	1.21B	1.68B	-11.91B	1.76B	1.93B	2.07B	2.26B	2.02B	1.61B	1.42B	1.28B	2.37B	1.55B	1.05B	2.02B
Selling & General & Admin	1.69B	1.58B	2.1B	1.98B	1.92B	2.36B	2.06B	1.94B	1.93B	1.76B	2.27B	1.86B	1.78B	1.83B	2.35B	1.79B	1.88B	1.67B
Research & Development	2.26B	2.24B	2.79B	2.35B	2.29B	2.69B	2.48B	2.18B	2.26B	2.3B	2.51B	2.36B	2.32B	2.22B	2.61B	3.25B	3.27B	2.22B
Other Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Expenses	3.95B	3.82B	4.89B	4.33B	4.22B	5.05B	4.54B	4.12B	4.19B	4.06B	4.78B	4.22B	4.1B	4.05B	4.96B	5.04B	5.15B	3.89B
Interest Expense	485M	494M	496M	505M	521M	425M	316M	280M	282M	288M	294M	299M	313M	326M	323M	328M	330M	353M
Selling & Marketing Expenses	n/a	1.58B	n/a	1.98B	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	8.15B	7.68B	9.81B	9.6B	9.62B	10.33B	9.53B	8.86B	9.28B	8.88B	9.69B	8.99B	9.2B	8.94B	9.75B	9.89B	10.14B	8.88B
Income Tax Expense	460M	509M	99M	461M	-398M	392M	-88M	203M	-218M	503M	-166M	601M	529M	404M	-514M	605M	492M	501M
Shares Outstanding (Basic)	2.04B	2.03B	2.03B	2.03B	2.03B	2.02B	2.03B	2.06B	2.09B	2.1B	2.11B	2.13B	2.13B	2.15B	2.15B	2.22B	2.23B	2.24B
Shares Outstanding (Diluted)	2.04B	2.04B	2.04B	2.03B	2.03B	2.02B	2.03B	2.06B	2.1B	2.11B	2.12B	2.15B	2.15B	2.16B	2.22B	2.24B	2.25B	2.27B
EPS (Basic)	0.64	1.21	0.04	0.60	0.83	-5.89	0.87	0.94	0.99	1.08	0.96	0.75	0.67	0.60	1.10	0.70	0.47	0.90
EPS (Diluted)	0.64	1.20	0.04	0.60	0.83	-5.89	0.87	0.93	0.99	1.07	0.95	0.75	0.66	0.59	1.07	0.69	0.47	0.89
EBITDA	3.29B	4.48B	2.55B	4.77B	4.4B	-8.56B	4.45B	4.85B	4.57B	5.49B	4.67B	5.1B	4.85B	4.6B	4.76B	5.21B	4.59B	5.55B
EBIT	2.26B	3.46B	671M	2.18B	1.81B	-11.09B	1.99B	2.4B	2.14B	3.06B	2.15B	2.51B	2.27B	2.01B	2.18B	2.48B	1.88B	2.88B
Depreciation & Amortization	1.03B	1.01B	1.88B	2.59B	2.6B	2.53B	2.46B	2.44B	2.43B	2.43B	2.52B	2.59B	2.58B	2.58B	2.58B	2.73B	2.71B	2.67B